Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	H/O DRUG ALLERGY TO ANY OF THE STUDY DRUGS <br/ >H/O ADVERSE DRUG REACTION TO ANY OF THE STUDY DRUGS <br/ > ELEVATED LIVER ENZYMES <br/ >H/O OCCULAR DISEASE <br/ >H/O CARDIO VASCULAR CONDUCTION DISEASE	H/O DRUG ALLERGY TO ANY OF THE STUDY DRUGS <br/ >H/O ADVERSE DRUG REACTION TO ANY OF THE STUDY DRUGS <br/ > ELEVATED LIVER ENZYMES <br/ >H/O OCCULAR DISEASE <br/ >H/O CARDIO VASCULAR CONDUCTION DISEASE
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
March 26, 2021, 2:21 p.m.	oms	H/O DRUG ALLERGY TO ANY OF THE STUDY DRUGS <br/ >H/O ADVERSE DRUG REACTION TO ANY OF THE STUDY DRUGS <br/ > ELEVATED LIVER ENZYMES <br/ >H/O OCCULAR DISEASE <br/ >H/O CARDIO VASCULAR CONDUCTION DISEASE	H/O DRUG ALLERGY TO ANY OF THE STUDY DRUGS <br/ >H/O ADVERSE DRUG REACTION TO ANY OF THE STUDY DRUGS <br/ > ELEVATED LIVER ENZYMES <br/ >H/O OCCULAR DISEASE <br/ >H/O CARDIO VASCULAR CONDUCTION DISEASE